39 results
424B3
PHIO
Phio Pharmaceuticals Corp
28 Dec 23
Prospectus supplement
9:13am
or indirectly, with any person to distribute the securities.
We are required to pay certain fees and expenses incurred incident to the registration
424B3
PHIO
Phio Pharmaceuticals Corp
20 Jun 23
Prospectus supplement
9:30am
are required to pay certain fees and expenses incurred incident to the registration of the securities. We have agreed to indemnify the Selling
8-K
EX-10.2
unb1ib7blb35bvaw3qy
2 Jun 23
Phio Pharmaceuticals Announces $4 Million Concurrent Registered Direct
4:30pm
8-K
EX-10.1
fkdad28 h1ntva2t9q6
2 Jun 23
Phio Pharmaceuticals Announces $4 Million Concurrent Registered Direct
4:30pm
8-K
EX-10.3
mjxt0bvfgx4
2 Jun 23
Phio Pharmaceuticals Announces $4 Million Concurrent Registered Direct
4:30pm
8-K
EX-10.1
9xb5kms9tzmmg 5d
20 Apr 23
Phio Pharmaceuticals Announces $2 Million Registered Direct
2:53pm
8-K
EX-3.1
nsr 3kv0f5l3phnnanw8
2 May 22
Changes in Control of Registrant
7:30am
8-K
EX-10.1
mo8n7hkrrrmpfbl7
17 Feb 21
Entry into a Material Definitive Agreement
4:15pm
424B2
ptqq83ygv1
9 Feb 21
Prospectus for primary offering
8:00am
8-K
EX-10.2
4pq1 rd5lr6n0194u
25 Jan 21
Entry into a Material Definitive Agreement
5:15pm
8-K
EX-10.1
cx2xm
25 Jan 21
Entry into a Material Definitive Agreement
5:15pm
8-K
EX-3.1
dsvvcd9llgdo ceyrnj5
13 Oct 20
Amendments to Articles of Incorporation or Bylaws
4:30pm
8-K
EX-10.1
l9qmgha ar
2 Apr 20
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-1.1
oysnn8fzc nv
13 Feb 20
Phio Pharmaceuticals Announces Pricing of $8.0 Million
5:25pm
8-K
EX-10.1
tcq1a
6 Feb 20
Entry into a Material Definitive Agreement
5:05pm